Media Coverage · February 1, 2015
LABIOTECH.fr: Acticor Biotech wins its crowdfunding bet!
Acticor Biotech réussi le pari du crowdfunding!
By Joachim – Published on January 29, 2015 | LABIOTECH.fr
Read in English : Biotech’s crowdfunding: is France top of the class?
In France, you can feel a real enthousiasme for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, develops an antibody inhibitor of arterial thrombosis, directed against the glycoprotein 6 (GP6), a new therapeutic target on the surface of platelets.[…]
Read next in 'Media Coverage'
- AVC : les promesses de la science - l'Express [FR]
- Pharmacie : La Chine s'éveille - Le Figaro [FR]
- AVC, un candidat médicament - La revue du practicien [FR]
- Un nouvel antithrombotique en développement - Le quotidien du pharmacien [FR]
- la start-up Acticor, qui développe un traitement contre les AVC, a bouclé une levée de fonds en série B de 15,3 millions d'euros - Les Echos [FR]